Heart failure (HF) affects 6.2 million people in the United States, with 1 million new cases occurring annually and a resultant 1 million hospitalizations, which translates into an annual estimated cost of over $30 billion dollars. Mortality with this condition is high, approximately 50% at five years. Implementation of the advances in management of heart failure have the potential to improve patients' quality of life, reduce the need for hospitalizations, reduce total medical costs, and prolong survival. This lecture will review the current evidence-based, guideline-recommended diagnosis and management of heart failure. You will learn the essential roles of evidence-based heart failure medications, device therapy, patient education, and disease management.

This initiative aims to increase understanding among cardiologists about adjunctive LDL-C-lowering therapies and their potential role in reducing residual ASCVD risk. During this series, national lipid expert faculty will discuss the incidence of and diagnostic criteria for statin intolerance, explain the mechanistic rationale for lowering LDL-C through nonstatin therapies, and explore novel targets and treatment pathways. It is expected to improve cardiologists’ management of patients with ‘tough-to-treat’ cholesterol according to the 2018 American Heart Association (AHA)/American College of Cardiology (ACC)/Multi-society Cholesterol Guidelines. Learners will have the opportunity to gain practical clinical perspectives during expert case study discussions. The patient scenarios will discuss how new treatment options may fit into the current therapeutic landscape.

In this session, the speaker will discuss some challenging diagnostic cases that primary care practitioners may face in their practice. These cases will feature interpretation of laboratory and imaging studies as well as encounters with rare diseases and conditions. You will learn which aspects of the history and physical exam are most useful to establish certain diagnoses, increase your awareness of certain uncommon but “can’t miss” diagnoses, and become familiar with clinical decision aids that improve diagnostic accuracy for certain common diagnoses. Please note that any data, indications, and guidelines presented in this activity are current as of the recording/release on February 8th, 2020, and they are subject to change as new information is published.

Stroke can be devastating and lead to significant disability and/or death. Diagnosing and treating stroke symptoms as well as factors associated with transient ischemic attacks—often a stroke warning sign—are of paramount importance. The faculty in this talk will discuss the crucial role of the primary care team in post-stroke care and how you can ensure the best recovery for your patients who have suffered from stroke.

In this session, you will receive the most important cardiology updates from 2018-2019, including trial evidence for dietary supplements in the prevention of cardiovascular disease and new information about the blood cholesterol guidelines. The session will also provide advice on how to differentiate between opportunistic and systematic screening for atrial fibrillation as well as identify ways to conduct this screening in practice. Please note that any data, indications, and guidelines presented in this activity are current as of the recording/release on February 8th 2020 and they are subject to change as new information is published.

In this session, you will receive the most important cardiology updates from 2018-2019, including trial evidence for dietary supplements in the prevention of cardiovascular disease and new information about the blood cholesterol guidelines. The session will also provide advice on how to differentiate between opportunistic and systematic screening for atrial fibrillation as well as identify ways to conduct this screening in practice.

Get your questions answered by expert faculty in Cardiology. You ask: we listen. You will learn practical solutions to common clinical challenges and tips to apply the latest knowledge in practice.

This talk on deep vein thrombosis (DVT) will review common clinical presentations, diagnostic workup, indications for imaging, and therapeutic options. The consequences of DVT, such as pulmonary embolism and stroke (in patients with patent foramen ovale), can be dire, and the faculty will provide strategies to reduce morbidity and mortality. You will dive into a detailed lesson on the medical therapy for DVT, which includes anticoagulation strategies using warfarin or the novel factor Xa inhibitors. After this session, you will know when to refer for more advanced invasive therapies and have insight into management of special populations. Please note that any data, indications, and guidelines presented in this activity are current as of the recording/release on February 9th, 2020, and they are subject to change as new information is published.

This program is designed to address some of the practical clinical issues from the recent literature. You will learn about controversies and caveats that will help you interpret recent updates. A few case examples of routine practice encounters will illustrate how to apply this new information in daily practice. Please note that any data, indications, and guidelines presented in this activity are current as of the recording/release on February 9, 2020, and they are subject to change as new information is published.

Stay up to date with the latest USPSTF recommendations for screening and preventive interventions in primary care. Hear about important changes regarding which patients should be screened for colorectal cancer, lung cancer, and hepatitis C virus infection. Walk away from this session with a firm grasp of the evidence of benefits vs harms for each of these recommendations so that you and your patients are positioned to make the best decisions for their care.

What do primary care providers need to know about glaucoma, hypertension, and asthma? Join ophthalmologist Yvonne Chu, cardiologist Karol Watson, and pulmonologist Sunjay Devarajan as they review important questions they get asked about these topics!

Peripheral artery disease affects nearly 9 million Americans and is associated with significantly increased risk of cardiovascular morbidity and mortality. Beyond initiation of therapies to reduce cardiovascular risk, many interventions used to treat peripheral artery disease aim to improve functional status and quality of life. Join us for this overview, where we'll review the epidemiology, classification, evaluation and treatment of this condition. Heart failure is a global pandemic that continues to increase in prevalence. Despite the availability of established and novel therapies, mortality and morbidity in heart failure remains high. Join us for this overview of heart failure classification and pathophysiology, the evidence base supporting various treatments, and current guideline recommendations.